Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cooper

Showing results (1521-1530 of 1,657) with videos related to

Pageof 166
Sort By:
Science Advances|March 15, 2024
Redirecting raltitrexed from cancer cell thymidylate synthase to <i>Mycobacterium tuberculosis</i> phosphopantetheinyl transferaseAmrita Singh, Samantha Ottavi, Inna Krieger, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2021
Racial Segregation and Respiratory Outcomes among Urban Black Residents with and at Risk of Chronic Obstructive Pulmonary DiseaseHan Woo, Emily P Brigham, Kassandra Allbright, et al.
American Journal of Respiratory and Critical Care Medicine|October 23, 2024
Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations: An Analysis of SPIROMICSMichael Burnim, Nirupama Putcha, David LaFon, et al.
The Lancet. Respiratory Medicine|July 3, 2017
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohortMeiLan K Han, Pedro M Quibrera, Elizabeth E Carretta, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Impact of Bronchiectasis on COPD Severity and Alpha-1 Antitrypsin Deficiency as a Risk Factor in Individuals with a Heavy Smoking HistoryManuel Izquierdo, Chad R Marion, Frank Genese, et al.
Journal of Medicinal Chemistry|June 2, 2012
Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitorsLalgudi S Harikrishnan, Heather J Finlay, Jennifer X Qiao, et al.
Annals of the American Thoracic Society|March 11, 2025
Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS CohortIgor Barjaktarevic, Roxana Hixson, Zian Zhuang, et al.
Annals of the American Thoracic Society|November 25, 2024
Phenotypes and Trajectories of Tobacco-exposed Persons with Preserved Spirometry: Insights from Lung VolumesMehrdad Arjomandi, Siyang Zeng, Igor Barjaktarevic, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory OutcomesChinedu O Ejike, Han Woo, Panagis Galiatsatos, et al.
Annals of the American Thoracic Society|May 2, 2017
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study CohortCarlos H Martinez, Susan Murray, R Graham Barr, et al.
Pageof 166

Showing results (1521-1530 of 1,657) with videos related to

Sort By:
Pageof 166
Science Advances|March 15, 2024
Redirecting raltitrexed from cancer cell thymidylate synthase to <i>Mycobacterium tuberculosis</i> phosphopantetheinyl transferaseAmrita Singh, Samantha Ottavi, Inna Krieger, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2021
Racial Segregation and Respiratory Outcomes among Urban Black Residents with and at Risk of Chronic Obstructive Pulmonary DiseaseHan Woo, Emily P Brigham, Kassandra Allbright, et al.
American Journal of Respiratory and Critical Care Medicine|October 23, 2024
Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations: An Analysis of SPIROMICSMichael Burnim, Nirupama Putcha, David LaFon, et al.
The Lancet. Respiratory Medicine|July 3, 2017
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohortMeiLan K Han, Pedro M Quibrera, Elizabeth E Carretta, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|May 18, 2023
Impact of Bronchiectasis on COPD Severity and Alpha-1 Antitrypsin Deficiency as a Risk Factor in Individuals with a Heavy Smoking HistoryManuel Izquierdo, Chad R Marion, Frank Genese, et al.
Journal of Medicinal Chemistry|June 2, 2012
Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitorsLalgudi S Harikrishnan, Heather J Finlay, Jennifer X Qiao, et al.
Annals of the American Thoracic Society|March 11, 2025
Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS CohortIgor Barjaktarevic, Roxana Hixson, Zian Zhuang, et al.
Annals of the American Thoracic Society|November 25, 2024
Phenotypes and Trajectories of Tobacco-exposed Persons with Preserved Spirometry: Insights from Lung VolumesMehrdad Arjomandi, Siyang Zeng, Igor Barjaktarevic, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory OutcomesChinedu O Ejike, Han Woo, Panagis Galiatsatos, et al.
Annals of the American Thoracic Society|May 2, 2017
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study CohortCarlos H Martinez, Susan Murray, R Graham Barr, et al.
Pageof 166